Long‐term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic–clonic seizures: An open‐label extension trial

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2024-10-26
DOI
https://doi.org/10.1111/epi.18158
Citations
4
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
1.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic–clonic seizures: An open‐label extension trial

David G. Vossler, Paulette Williams, Carrie McClung, И. Е. Повереннова et al.
4 citations
Epilepsia
Epilepsy research and treatment
1.54
article

Long‐term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic–clonic seizures: An open‐label extension trial

David G. Vossler, Paulette Williams, Carrie McClung, И. Е. Повереннова, Terence John O'Brien, Robert Roebling, Mark Kristof Farkas, Svetlana Dimova, Masako Watanabe, Peter Conrath
article en
4 citations

Abstract

No abstract available for this paper.
EpilepsiaVol. 65(12)
Semmelweis University (HU), University of Washington (US), National Center of Neurology and Psychiatry (JP), Samara Regional Clinical Hospital named after V.D. Seredavina (RU), Alfred Health (AU), UCB Pharma (Germany) (DE), Monash University (AU), UCB Pharma (Belgium) (BE)
UCB
Openalex Percentile: Top 16%
Epilepsy research and treatment
1.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.